bearish

Joinn Laboratories (H)

Joinn Laboratories (6127.HK) 22H1 - It's Time to Face Reality Before the Magic of Monkeys Disappears

The logic chain of "monkey shortage-monkey price rise-Joinn’s performance increase" has shaken.Faced with doubts about future prosperity of CXO,Joinn isn't immune. It's hard to achieve V-shape rebound

Equity Bottom-Up
164 Views, 29 Sep 2022 08:39
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • MicroPort NeuroTech (2172.HK) 22H1 - Advantages Deserve Recognition, but with Overvaluation Risk
    06 Oct 2022
  • Shanghai United Imaging Healthcare (688271.CH) - Overvalued; Stock Price Will Return to Rationality
    04 Oct 2022
  • China Healthcare Weekly (Sep.30) - Orthopedics VBP, CGT CDMO, Surgical Robots, Bottom of HKEX
    02 Oct 2022
  • Joinn Laboratories (6127.HK) 22H1 - It's Time to Face Reality Before the Magic of Monkeys Disappears
    29 Sep 2022
  • About the CXO Plunge After Biden Signed National Biotechnology and Biomanufacturing Initiative
    19 Sep 2022
  • PCAOB and CSRC‘s Agreement on Audit Terms Could Fail - The Real Test of China ADRs Lies Ahead
    08 Sep 2022
  • US-China Decoupling: The Impact on China Healthcare
    25 Aug 2022
  • Wuxi Biologics (2269.HK) 2022H1 - Hard to Achieve V-Share Rebound
    22 Aug 2022
  • Joinn Laboratories (6127.HK) - Concerns Begin to Arise when the Monkeys Become More Expensive
    01 Dec 2021
x